Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences, Inc. (FBRX) Return on Equity (2017 - 2020)

Forte Biosciences (FBRX) has disclosed Return on Equity for 4 consecutive years, with 2.35% as the latest value for Q3 2020.

  • On a quarterly basis, Return on Equity fell 1066.0% to 2.35% in Q3 2020 year-over-year; TTM through Sep 2020 was 2.35%, a 1066.0% decrease, with the full-year FY2019 number at 23.08%, up 2447.0% from a year prior.
  • Return on Equity was 2.35% for Q3 2020 at Forte Biosciences, up from 5.56% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 39.9% in Q1 2019 to a low of 5.56% in Q2 2020.
  • A 4-year average of 3.37% and a median of 0.44% in 2017 define the central range for Return on Equity.
  • Peak YoY movement for Return on Equity: surged 4056bps in 2019, then crashed -3976bps in 2020.
  • Forte Biosciences' Return on Equity stood at 0.52% in 2017, then crashed by -303bps to 2.08% in 2018, then skyrocketed by 283bps to 3.8% in 2019, then tumbled by -162bps to 2.35% in 2020.
  • Per Business Quant, the three most recent readings for FBRX's Return on Equity are 2.35% (Q3 2020), 5.56% (Q2 2020), and 0.15% (Q1 2020).